To provide a novel radioactive octreotide derivative, which is glycosylated and bound to a somatostatin receptor.
There is provided an improved sst-receptor binding peptidic ligand for the diagnosis and therapeutic application in nuclear medicine. The improved ligand includes a natural or unnatural amino acid or peptidomimetic structure, a carbohydrate unit and a chelator or a prosthetic group, at N-terminal or at C-terminal or at both terminals thereof to provide a complexion formation of a radioisotope, which binds or holds the radioisotope. The sst- or SSTR-receptor binding peptidic ligand may contain one or more multifunctional linker units optionally coupling the peptide, and/or a sugar moiety and/or a chelator and/or a prosthetic group.
| JP3959431 | REGIONAL SPECIFIC THERAPY AND MEANS |
| JP2001521515 | [Title of Invention] Chelating agent |
| WO/2006/096656 | METHODS OF APPLYING IONIZATION RADIATION FOR THERAPY OF HIV INFECTION |
SCHOTTELIUS MARGRET
SCHWAIGER MARKUS
Next Patent: DRUG CARRIER AND DRUG CARRIER KIT FOR INHIBITING FIBROSING